Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-09-27

Clinical Trial Update: The Effects of Beta-glucan Enriched Oatcake Consumption on Metabolic Disease Risk Factors [NA]

View source ↗

Summary

This clinical trial update investigates whether beta-glucan enriched oatcake affects metabolic syndrome and cardiovascular disease risk factors. The current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Queen Margaret University | Conditions: Metabolic Syndrome X, Cardiovascular Diseases | NA | Status: UNKNOWN